Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
Authors
Chancellor, John R.Padmanabhan, Sriranjani P.
Greenough, Thomas C.
Sacra, Richard
Ellison, Richard T. III
Madoff, Lawrence C.
Droms, Rebecca
Hinkle, David
Asdourian, George
Finberg, Robert W.
Stroher, Ute
Uyeki, Timothy M.
Cerón, Olga M.
UMass Chan Affiliations
Department of Ophthalmology and Visual SciencesDepartment of Family Medicine and Community Health
Department of Medicine, Division of Infectious Diseases and Immunology
School of Medicine
Document Type
Journal ArticlePublication Date
2016-02-01Keywords
Ebola hemorrhagic feverEbola virus disease
Ebola
Ebola virus
viruses
uveitis
conjunctivitis
ocular manifestations
systemic inflammatory markers
immune privilege
convalescent phase
Liberia
Allergy and Immunology
Eye Diseases
Immunology and Infectious Disease
Infectious Disease
Ophthalmology
Pathological Conditions, Signs and Symptoms
Virus Diseases
Metadata
Show full item recordAbstract
We report a case of probable Zaire Ebola virus-related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia. Uveitis, immune activation, and nonspecific increase in antibody titers developed during convalescence. This case highlights immune phenomena that could complicate management of Ebola virus disease-related uveitis during convalescence.Source
Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT 3rd, Madoff LC, Droms RJ, Hinkle DM, Asdourian GK, Finberg RW, Stroher U, Uyeki TM, Cerón OM. Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis. 2016 Feb;22(2):295-7. doi: 10.3201/eid2202.151416. PMID: 26812218; PMCID: PMC4734519. Link to article on publisher's site
DOI
10.3201/eid2202.151416Permanent Link to this Item
http://hdl.handle.net/20.500.14038/35183PubMed ID
26812218Related Resources
Rights
Emerging Infectious Diseases is published by the Centers for Disease Control and Prevention, a U.S. Government agency. Therefore, materials published in Emerging Infectious Diseases, including text, figures, tables, and photographs are in the public domain and can be reprinted or used without permission with proper citation.ae974a485f413a2113503eed53cd6c53
10.3201/eid2202.151416
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus DiseaseGenisca, Alicia E.; Chu, Tzu-Chun; Huang, Lawrence; Gainey, Monique; Adeniji, Moyinoluwa; Mbong, Eta N.; Kennedy, Stephen B.; Laghari, Razia; Nganga, Fiston; Muhayangabo, Rigo F.; et al. (2022-06-01)Rapid diagnostic tools for children with Ebola virus disease (EVD) are needed to expedite isolation and treatment. To evaluate a predictive diagnostic tool, we examined retrospective data (2014-2015) from the International Medical Corps Ebola Treatment Centers in West Africa. We incorporated statistically derived candidate predictors into a 7-point Pediatric Ebola Risk Score. Evidence of bleeding or having known or no known Ebola contacts was positively associated with an EVD diagnosis, whereas abdominal pain was negatively associated. Model discrimination using area under the curve (AUC) was 0.87, which outperforms the World Health Organization criteria (AUC 0.56). External validation, performed by using data from International Medical Corps Ebola Treatment Centers in the Democratic Republic of the Congo during 2018-2019, showed an AUC of 0.70. External validation showed that discrimination achieved by using World Health Organization criteria was similar; however, the Pediatric Ebola Risk Score is simpler to use.
-
The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and ResponseBotti-Lodovico, Yolanda; Colubri, Andres; Sabeti, Pardis C.; Happi, Christian (2021-08-13)While investigating a signal of adaptive evolution in humans at the gene LARGE, we encountered an intriguing finding by Dr. Stefan Kunz that the gene plays a critical role in Lassa virus binding and entry. This led us to pursue field work to test our hypothesis that natural selection acting on LARGE-detected in the Yoruba population of Nigeria-conferred resistance to Lassa Fever in some West African populations. As we delved further, we conjectured that the "emerging" nature of recently discovered diseases like Lassa fever is related to a newfound capacity for detection, rather than a novel viral presence, and that humans have in fact been exposed to the viruses that cause such diseases for much longer than previously suspected. Dr. Stefan Kunz's critical efforts not only laid the groundwork for this discovery, but also inspired and catalyzed a series of events that birthed Sentinel, an ambitious and large-scale pandemic prevention effort in West Africa. Sentinel aims to detect and characterize deadly pathogens before they spread across the globe, through implementation of its three fundamental pillars: Detect, Connect, and Empower. More specifically, Sentinel is designed to detect known and novel infections rapidly, connect and share information in real time to identify emerging threats, and empower the public health community to improve pandemic preparedness and response anywhere in the world. We are proud to dedicate this work to Stefan Kunz, and eagerly invite new collaborators, experts, and others to join us in our efforts.
-
Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational DynamicsDurham, Natasha D.; Howard, Angela R.; Govindan, Ramesh; Senjobe, Fernando; Fels, J. Maximilian; Diehl, William E.; Luban, Jeremy; Chandran, Kartik; Munro, James B (2020-01-15)The Ebola virus (EBOV) envelope glycoprotein (GP) mediates the fusion of the virion membrane with the membrane of susceptible target cells during infection. While proteolytic cleavage of GP by endosomal cathepsins and binding of the cellular receptor Niemann-Pick C1 protein (NPC1) are essential steps for virus entry, the detailed mechanisms by which these events promote membrane fusion remain unknown. Here, we applied single-molecule Forster resonance energy transfer (smFRET) imaging to investigate the structural dynamics of the EBOV GP trimeric ectodomain, and the functional transmembrane protein on the surface of pseudovirions. We show that in both contexts, pre-fusion GP is dynamic and samples multiple conformations. Removal of the glycan cap and NPC1 binding shift the conformational equilibrium, suggesting stabilization of conformations relevant to viral fusion. Furthermore, several neutralizing antibodies enrich alternative conformational states. This suggests that these antibodies neutralize EBOV by restricting access to GP conformations relevant to fusion. This work demonstrates previously unobserved dynamics of pre-fusion EBOV GP and presents a platform with heightened sensitivity to conformational changes for the study of GP function and antibody-mediated neutralization.